<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04753385</url>
  </required_header>
  <id_info>
    <org_study_id>LND300</org_study_id>
    <nct_id>NCT04753385</nct_id>
  </id_info>
  <brief_title>The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes</brief_title>
  <acronym>UNCOVER</acronym>
  <official_title>The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LivaNova</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LivaNova</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to collect both active and passive data using a wearable,&#xD;
      multi-sensor device (Verily Study Watch) and phone application (Mood App) which aims to&#xD;
      capture mental health status, in subjects participating in the RECOVER clinical trial (A&#xD;
      Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and&#xD;
      Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in&#xD;
      Subjects With Treatment-Resistant Depression).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective, observational, exploratory study collecting passive and active behavioral,&#xD;
      environmental and physiological data, via the use of an Android smartphone application and&#xD;
      Study Watch.&#xD;
&#xD;
      This sub-study is only open to sites participating in the RECOVER clinical study.&#xD;
&#xD;
      All subjects participating in the RECOVER clinical trial that currently own an Android&#xD;
      smartphone will be offered participation in this sub-study.&#xD;
&#xD;
      Subjects who opt-in to the Mood App portion of the sub-study will be followed for a minimum&#xD;
      of 12 months and a maximum of 60 months for the Mood App portion of the sub-study.&#xD;
&#xD;
      Subjects who also opt-in to the use of the Study Watch portion of the sub-study will be&#xD;
      followed for a minimum of 12 months and maximum of 24 months for the Study Watch portion of&#xD;
      the sub-study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 23, 2021</start_date>
  <completion_date type="Anticipated">October 2024</completion_date>
  <primary_completion_date type="Anticipated">October 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of PHQ-8 tasks</measure>
    <time_frame>Through study completion; Average 2 years</time_frame>
    <description>Percentage of PHQ-8 tasks completed over the duration of the study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Voice Diary tasks</measure>
    <time_frame>Through study completion; Average 2 years</time_frame>
    <description>Percentage of Voice Diary tasks completed over the duration of the study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of ping sensor recordings</measure>
    <time_frame>Through study completion; Average 2 years</time_frame>
    <description>Number of ping sensor recordings over the duration of the study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of hours of watch wear time</measure>
    <time_frame>Through study completion; Average 2 years</time_frame>
    <description>Number of hours of watch wear time over the duration of the study</description>
  </primary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Treatment Resistant Depression</condition>
  <eligibility>
    <study_pop>
      <textblock>
        This sub-study is only open to sites participating in the RECOVER clinical study.&#xD;
&#xD;
        Every subject that currently owns an Android smartphone will be offered to opt-in to the&#xD;
        sub-study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        All Subjects&#xD;
&#xD;
          1. Current consented subject in the RECOVER clinical trial;&#xD;
&#xD;
          2. Adult (i.e. ≥ 18 years of age, unless a resident of any U.S. state where the age of&#xD;
             majority is 19, in which case must be ≥ 19 years of age);&#xD;
&#xD;
          3. Able and willing to provide written informed consent for this sub-study;&#xD;
&#xD;
          4. Able and willing to comply with all study procedures;&#xD;
&#xD;
          5. Able to read and speak English.&#xD;
&#xD;
        Phone Application&#xD;
&#xD;
          1. Have a personal Google user account or be willing to create and own a personal Google&#xD;
             user account;&#xD;
&#xD;
          2. Owns a personal Android smartphone with a data plan and is the sole user of that&#xD;
             smartphone;&#xD;
&#xD;
          3. Agrees to download and maintain the phone application onto personal Android smartphone&#xD;
             for the duration of the sub-study;&#xD;
&#xD;
        Study Watch&#xD;
&#xD;
        1. Willing to comply with Study Watch wearing and recharging requirements&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        All Subjects&#xD;
&#xD;
        1. Any condition or situation the Principal Investigator determines as inappropriate for&#xD;
        study inclusion&#xD;
&#xD;
        Phone Application&#xD;
&#xD;
        No additional exclusion criteria for phone application&#xD;
&#xD;
        Study Watch&#xD;
&#xD;
        1. Subjects with known severe allergy to nickel or metal jewelry&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charles Conway, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shannon L Majewski</last_name>
    <phone>(817) 771-9195</phone>
    <email>shannon.majewski@livanova.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jeff Way</last_name>
    <phone>(281) 228-7394</phone>
    <email>jeffrey.way@livanova.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>ATP Clinical Research, Inc.</name>
      <address>
        <city>Costa Mesa</city>
        <state>California</state>
        <zip>92626</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bobby Shih</last_name>
      <phone>714-277-4472</phone>
      <email>bshih@atpcr.com</email>
    </contact>
    <investigator>
      <last_name>Gustavo Alva, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mindful Behavioral Health</name>
      <address>
        <city>Boca Raton</city>
        <state>Florida</state>
        <zip>33431</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Stepler</last_name>
      <phone>561-499-6933</phone>
      <email>astepler@gminstitutes.com</email>
    </contact>
    <investigator>
      <last_name>Ivan Cichowicz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Segal Trials Corporate</name>
      <address>
        <city>Lauderhill</city>
        <state>Florida</state>
        <zip>33319</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fedor Richani</last_name>
      <phone>954-990-6326</phone>
      <email>frichani@segaltrials.com</email>
    </contact>
    <contact_backup>
      <last_name>Courtney Talbert</last_name>
      <phone>954-990-6326</phone>
      <email>ctalbert@segaltrials.com</email>
    </contact_backup>
    <investigator>
      <last_name>Rishi Kakar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Central Miami Medical Institute, LLC</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33125</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Ocana</last_name>
      <phone>305-547-2011</phone>
      <email>mocana@gminstitutes.com</email>
    </contact>
    <investigator>
      <last_name>Leonardo Alonso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>APG Research, LLC</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matt Bubal</last_name>
      <phone>407-808-1875</phone>
      <email>apgresearch.bubalo@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Morteza Nadjafi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Mental Health Care Inc.</name>
      <address>
        <city>Royal Palm Beach</city>
        <state>Florida</state>
        <zip>33411</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elyssa Sisko</last_name>
      <phone>561-333-8884</phone>
      <email>Amhc.phones@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Aron Tendler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Center for TMS</name>
      <address>
        <city>Saint Augustine</city>
        <state>Florida</state>
        <zip>94901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jason R Fritz</last_name>
      <phone>850-212-6262</phone>
      <email>jfritz01@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Heather Luing, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stedman Clinical Trials</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33613</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Fowler</last_name>
      <phone>813-971-8311</phone>
      <email>susan_fowler@stedmanclinicaltrials.com</email>
    </contact>
    <investigator>
      <last_name>Mary L Stedman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Psychiatric Medicine Associates, LLC</name>
      <address>
        <city>Skokie</city>
        <state>Illinois</state>
        <zip>60076</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda White</last_name>
      <phone>847-679-8000</phone>
      <phone_ext>12</phone_ext>
      <email>awhite.pma@gmail.com</email>
    </contact>
    <investigator>
      <last_name>John Zajecka, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southern Illinois University School of Medicine</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62794</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vineela Sunkepalli</last_name>
      <phone>217-545-7321</phone>
      <email>vsunkepalli85@siumed.edu</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Bennett, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beacon Medical Group Behavioral Health</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vanessa DePue, RN</last_name>
      <phone>574-647-6584</phone>
      <email>Vdepue@beaconhealthsystem.org</email>
    </contact>
    <investigator>
      <last_name>Ahmed Elmaadawi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aaronson</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MacKenzie Forbes</last_name>
      <phone>410-938-3135</phone>
      <email>MForbes@sheppardpratt.org</email>
    </contact>
    <investigator>
      <last_name>Scott Aaronson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Michigan Clinical Research Institute PC</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Szczesniak</last_name>
      <phone>734-834-8954</phone>
      <phone_ext>2</phone_ext>
      <email>amandas@earlytreatment.org</email>
    </contact>
    <investigator>
      <last_name>Rajaprabhakaran Rajarethinam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alivation Research, LLC</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68526</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Espenschade</last_name>
      <phone>402-817-2235</phone>
      <email>KEspenschade@alivation.com</email>
    </contact>
    <investigator>
      <last_name>Walter Duffy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Erie County Medical Center/State University of New York (SUNY) at Buffalo Affiliate</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sevie Kandefer</last_name>
      <phone>716-898-4038</phone>
      <email>sk293@buffalo.edu</email>
    </contact>
    <investigator>
      <last_name>Biswarup Ghosh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hapworth Research Inc.</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10019</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariah Garcia</last_name>
      <phone>212-956-2000</phone>
      <email>mgarcia@treatmentonline.com</email>
    </contact>
    <investigator>
      <last_name>William Hapworth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SUNY Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marielle N De masi</last_name>
      <phone>315-464-1670</phone>
      <email>demasim@upstate.edu</email>
    </contact>
    <investigator>
      <last_name>Thomas Schwartz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rivus Wellness &amp; Research Institute</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marvin Peyton (PI), MD</last_name>
      <phone>405-753-4994</phone>
      <email>drpeyton@rivusinstitute.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Scranton Medical Institutes</name>
      <address>
        <city>Moosic</city>
        <state>Pennsylvania</state>
        <zip>18507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Kane</last_name>
      <phone>570-346-3686</phone>
      <phone_ext>172</phone_ext>
      <email>ckane@gminstitutes.com</email>
    </contact>
    <investigator>
      <last_name>Matthew Berger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>BioBehavioral Research of Austin</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78759</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Candice Peel</last_name>
      <phone>512-382-6661</phone>
      <email>candice@bbraustin.com</email>
    </contact>
    <investigator>
      <last_name>Charles Sweet, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>North Pointe Psychiatry</name>
      <address>
        <city>Lewisville</city>
        <state>Texas</state>
        <zip>75057</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sahar Ashraf</last_name>
      <phone>469-444-2244</phone>
      <email>sahar_ashraf07@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Asad Islam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Neuropsychiatric Associates, Plc</name>
      <address>
        <city>Woodstock</city>
        <state>Vermont</state>
        <zip>05091</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Shaw</last_name>
      <phone>802-457-4904</phone>
      <email>sshaw@woodstockresearch.org</email>
    </contact>
    <investigator>
      <last_name>Susan Smiga, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carilion Clinic</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24014</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bryce Lewis</last_name>
      <phone>540-494-8285</phone>
      <email>brlewis@carilionclinic.org</email>
    </contact>
    <investigator>
      <last_name>Anita Kablinger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center for Anxiety and Depression</name>
      <address>
        <city>Mercer Island</city>
        <state>Washington</state>
        <zip>98040</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heidi Brandli</last_name>
      <phone>206-230-0330</phone>
      <email>hbrandli@comcast.net</email>
    </contact>
    <investigator>
      <last_name>David Dunner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 7, 2021</study_first_submitted>
  <study_first_submitted_qc>February 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2021</study_first_posted>
  <last_update_submitted>September 16, 2021</last_update_submitted>
  <last_update_submitted_qc>September 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Depression</keyword>
  <keyword>TRD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder, Treatment-Resistant</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

